Delivery Order SPE2DB22D1106-SPE2DB25FFHA6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) under a firm fixed-price contract. The delivery order, valued at $2,593.20 with an ultimate completion date of August 15, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $4,030.20. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on June 10, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This contract was competitively awarded without any set-aside designation and is structured as a firm fixed price delivery order. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $2,392.82 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of NovoLog 100 Unit/mL vials in 10mL quantities. This competitively awarded, firm fixed price delivery order is scheduled for completion by June 20, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,265.12 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). This firm fixed price contract, with performance in Conshohocken, Pennsylvania, represents a child delivery order issued under a larger indefinite delivery contract vehicle. The award involves no set-aside designation, indicating it was competitively awarded through open procurement processes. This delivery order falls...
- The Defense Logistics Agency awarded a $4,993.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL format) on September 17, 2025, with an ultimate completion date of September 18, 2025. This is an unclassified delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,712.00 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). This firm fixed price, non-set-aside delivery order is scheduled for completion by September 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply chain requirements,...
- The Defense Logistics Agency awarded a $2,737.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). The contract, which is a child order under a larger indefinite delivery contract, carries an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive, competitively awarded transaction...
- The Defense Logistics Agency awarded a $1,275.43 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL), an insulin product used in diabetes management. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,376.67 on June 2, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's broader...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHA6Delivery Order
The Defense Logistics Agency awarded a $4,048.85 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). The contract, classified as firm fixed price with no set-aside designation, is scheduled for completion by September 8, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award to a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/5/25 |